From Research to Clinical Practice – SaxoCell CLINICs Workshop 2026
How can innovative research findings be successfully translated into clinical applications? This question was the focus of this year’s SaxoCell CLINICs workshop, “From Research to Clinical Practice,” held on September 8, 2026, at the Study Center of Leipzig University Hospital. Approximately 60 participants from the fields of research, clinical practice, regulation, ethics, and industry gathered to discuss current developments and share practical experiences.
Moderated by Klaus Metzeler and Marco Herling, the workshop examined key challenges and success factors in the translation of cell and gene therapies. The agenda included, among other topics, current developments in CAR-T cell therapy, new approaches to treating solid tumors, gender-specific aspects of clinical trials, and issues related to ethics, regulation, ATMP manufacturing, and clinical trials.
The practical and interactive presentations by the speakers were particularly valuable. Markus Eckardt from the Ethics Committee of the University of Leipzig’s Faculty of Medicine presented ethical issues surrounding clinical trials, compassionate use programs, and individual therapeutic trials in a clear and accessible manner. Martina Schüssler-Lenz, a former member of PEI and EMA and a member of the SaxoCell Advisory Board, provided in-depth insight into regulatory requirements for the development and approval of ATMPs.
In his interactive presentation on ATMP manufacturing, Mirko Müller from Fraunhofer IZI provided a practical, hands-on understanding of GMP requirements. The program was rounded out by presentations from Vladan Vucinic on CAR-T cell therapy, Ulrich Hacker on the treatment of solid tumors, and Paul Warncke on gender-specific differences in clinical trials.
Case studies and interactive formats provided numerous points of reference for in-depth discussions and facilitated the exchange of diverse perspectives. Even the breaks were actively used for personal exchanges and networking.
The CLINICs Workshop is an established SaxoCell format: a workshop with a similar focus was already held during the first funding phase. By continuing this initiative in the second funding phase, SaxoCell once again underscores the importance of dialogue between research, clinical practice, industry, regulatory bodies, and ethics for the successful translation of cell and gene therapies.
We extend our heartfelt thanks to all speakers, moderators, and participants for their valuable contributions, open discussions, and in-depth exchanges.
